USFDA -

July 9, 2025
Food Supplements
What the New FDA “Healthy” Claim Rule Means for Food Labels in 2025
April 21, 2025
Medicinal Products,
Regulatory Affairs
The Regulatory Impact of Breakthrough Therapies on Post-Approval Changes
January 16, 2025
freya fusion
USFDA's eCTD 4.0 Update: Key Takeaways
November 15, 2024
Medicinal Products,
Regulatory Affairs
7 Ways AI is Impacting Regulatory Bodies Across the Globe
August 14, 2024
Food Supplements
US FDA Revokes Regulation on Brominated Vegetable Oil: A Step Towards Healthier Food Products
November 2, 2023
Medicinal Products,
Publishing and Submission
Navigating Regulatory Submissions in a Data-Driven World
October 27, 2023
Medicinal Products,
Medical Writing
Rise of Biopharmaceuticals: A US FDA's Perspective and the Crucial Role of Regulatory Vendors
September 20, 2023
Medicinal Products,
Labeling
Pediatric Drug Labeling Requirements in the EU and US - A Comparative Analysis
August 25, 2023
Medical Devices,
Regulatory Affairs
Gaining Regulatory Clarity: When to Seek Pre-RFD Feedback from the US FDA
August 25, 2023
Medical Devices,
Regulatory Affairs
Cracking the Code: Understanding Medical Device Manufacturing License Renewal Regulations in South Korea (Complainant’s Guide)
July 25, 2023
Medical Devices,
Regulatory Affairs
USFDA to Harmonize 21 CFR Part 820 with ISO 13485:2016 Starting December 2023: What Do Medical Device Manufacturers Need to Know?
July 25, 2023
Medical Devices,
EU Compliance
Radiation Emitting Devices and Products: Understanding USFDA's Labeling Requirements